Alan M. Fogelman

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

A. D. Watson, J A Berliner, Susan Hama et al. · Journal of Clinical Investigation · 1995 · 1.2K citations · Full text

Lipid Peroxidation, Inactive Hplc Fractions, Redox Biology +17

Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.

S D Cushing, J A Berliner, Anthony J. Valente et al. · Proceedings of the National Academy of Sciences · 1990 · 1.1K citations · Full text

Immunology, Biological Microenvironments, Pathology +19

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

Diana M. Shih, Lingjie Gu, Yu-Rong Xia et al. · Nature · 1998 · 1.1K citations

Inflammation, Serum Paraoxonase, Medicine +11

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.

J A Berliner, Mary Territo, Alex Sevanian et al. · Journal of Clinical Investigation · 1990 · 930 citations · Full text

Vascular Disease, Immunology, Oxidative Stress +18

Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages

Alan M. Fogelman, Ishaiahu Shechter, J Seager et al. · Proceedings of the National Academy of Sciences · 1980 · 848 citations · Full text